Effect of Venglustat in Patients With Renal Impairment

Summary

Primary Objective: To study the effect of mild, moderate and severe renal impairment on the pharmacokinetics (PK) of Venglustat following a single dose. Secondary Objective: To assess the tolerability of Venglustat given as a single dose in subjects with mild, moderate and severe renal impairment in comparison with matched subjects with normal renal function.

Timeline

Start

2018-10-05

Primary completion

2019-02-27

Completion

2019-02-27

Drugs

Indications